LORENZO OMANDAC: Open Payments
NPI 1487178927 · LAS VEGAS, NV. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,663 in 39 payments from 9 companies in 2025. Trend: 2023 $1,612 · 2024 $1,062 · 2025 $1,663
Food & beverage: $1,663
| Company | Payments | Amount |
|---|---|---|
| Boston Scientific Corporation | 9 | $750 |
| Medtronic, Inc. | 10 | $341 |
| BIOTRONIK NRO, Inc. | 7 | $307 |
| Forte Bio-Pharma LLC | 6 | $146 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 2 | $47 |
| Collegium Pharmaceutical, Inc. | 2 | $30 |
| Globus Medical, Inc. | 1 | $20 |
| Saluda Medical Americas, Inc. | 1 | $17 |
| SPR Therapeutics, Inc | 1 | $7 |
Products named: Intracept, INCEPTIV, General - Pain Management, Prospera, PROLATE, RELISTOR, Belbuca, INTELLIS ADAPTIVESTIM.
Industry payments across NV — which companies pay providers there.
